bpc 157 ban FDA panel votes to loosen restrictions for controversial peptides FDA to weigh easing limits

What are the benefits of BPC-157 peptide therapy

When the people vouching for a drug also sell it, dont take their word for it

FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list The vote is non-binding and still needs sign-off from the FDA

It also has not been approved by the European Medicines Agency or any other major health regulator in other countries

The reason is straightforward: tendons and ligaments have poor native blood supply, which means they heal slowly under the best circumstances and often stop progressing entirely after initial recovery

The peptide derives from a portion of a protein called Body Protection Compound, naturally found in human gastric juice